680 ADOPTIVE TRANSFER OF PSMA-SPECIFIC, TGF-β INSENSITIVE MEMORY CD8+ T CELLS: SUPPRESSION OF HUMAN PROSTATE CANCER (CAP)
Qiang Zhang,Brian Helfand,Lin Chen,Weijun Qin,Norm Smith,Julie Zhu,Yinglu Guo,Chung Lee
DOI: https://doi.org/10.1016/j.juro.2010.02.1079
2010-01-01
Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research V1 Apr 2010680 ADOPTIVE TRANSFER OF PSMA-SPECIFIC, TGF-β INSENSITIVE MEMORY CD8+ T CELLS: SUPPRESSION OF HUMAN PROSTATE CANCER (CAP) Qiang Zhang, Brian Helfand, Lin Chen, Weijun Qin, Norm Smith, Julie Zhu, Yinglu Guo, and Chung Lee Qiang ZhangQiang Zhang Chicago, IL More articles by this author , Brian HelfandBrian Helfand Chicago, IL More articles by this author , Lin ChenLin Chen Chicago, IL More articles by this author , Weijun QinWeijun Qin Xian, People's Republic of China More articles by this author , Norm SmithNorm Smith Chicago, IL More articles by this author , Julie ZhuJulie Zhu Boston, MA More articles by this author , Yinglu GuoYinglu Guo Beijing, People's Republic of China More articles by this author , and Chung LeeChung Lee Chicago, IL More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1079AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Tumor derived TGF-β is a potent immunosuppressant molecule which promotes CaP progression. Here we report a new immunotherapeutic approach using the adoptive transfer of PSMA-specific, TGF-β insensitive human memory CD8+ T cells to inhibit solid xenograft CaP. METHODS Whole blood was collected from men with CaP prior to prostatectomy and CD45RAhighCD27-CD28-CCR7- memory CD8+ T cells were isolated using the EasySep CD8+ T cells enrichment kit, and then cultured in the presence of both fresh PSMA and irradiated autologous CD4+ T cells. We developed an anti-PSMA-vβ12-ζ-IRES-TβRIIDN chimeric T cell receptor construct (PZ-1-TβRIIDN) using an anti-PSMA IgTCR(ζ) gene (provided by Dr. Sadelain at Sloan-Kettering Cancer Center) and a dominant negative TGF-β type II receptor (TβRIIDN). Infection with a retroviral vector encoding this construct could induce memory T cells to be PSMA reactive and insensitive to TGF-β. Subcutaneous injection (5x105 cells) of either PC-3 CaP cells (PSMA negative; ATCC) or PSMA positive PC-3-PSMA cells (gift from Dr. Heston; Cleveland Clinic) into the right flank region of 15 immunodeficient RAG-1 mice was performed. Three weeks later, each set of animals was randomly assigned to one of three adoptive transfer groups: Group 1: memory CD8+ T cells infected with PZ-1-TβRIIDN; Group 2: memory CD8+ T cells infected with TβRIIDN only and Group 3: no treatment control. The animals were sacrificed after a total of 2 adoptive transfer treatments. The size and the weight of tumor and spleen were recorded. RESULTS In Group 1 of PC-3-PSMA injected mice, the average tumor weight and volume of these mice was 2.62 g and 384.67 mm2, respectively. This was almost significantly less (∼2-5 x) than that of animals in Group 2 (6.20g and 646.56 mm2) and Group 3 (11.66g and 752.24 mm2; P<0.05). Also, there was a significant difference between Groups 2 and 3. Interestingly, spleen weight of Group 1 (48.8mg) and Group 2 (64.5mg) increased compared to Group 3 (35.3 mg). Apoptosis in tumor cells was detected (TUNEL assay) only in animals of Group 1. There was no significant difference between the tumor size and weight in any of the three PC-3 injected groups. CONCLUSIONS Tumor derived TGF-β decreases the function of host memory CD8+ T cells. Our approach combines TGF-β-insensitive with PSMA selectivity, which significantly enhance the specificity and tumor killing ability of multi-clonal CD8+ memory T cells. Therefore, this construct may offer a novel therapeutic intervention for both primary CaP treatment as well as for recurrence after prostatectomy. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e265-e266 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Qiang Zhang Chicago, IL More articles by this author Brian Helfand Chicago, IL More articles by this author Lin Chen Chicago, IL More articles by this author Weijun Qin Xian, People's Republic of China More articles by this author Norm Smith Chicago, IL More articles by this author Julie Zhu Boston, MA More articles by this author Yinglu Guo Beijing, People's Republic of China More articles by this author Chung Lee Chicago, IL More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...